Andrew N Holding is an expert in Biochemistry at University of York (United Kingdom). Andrew N Holding has authored 35 publications, the most recent in 2026. SLR score: 133 (community average: 125). How the SLR is computed.

LeadR Profile

Andrew N Holding University of York United Kingdom
133 ScienceLeadR Reputation 133
Network Map

Biochemistry

Subspecialties: Hematology - Genetics - Endocrinology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2009 - 2026

Source: PubMed

University of York

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 35

Citations

Citations: 705 1st author: 11 Last author: 5 Unique author: 2


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Aberrant splicing of MBD1 reshapes the epigenome to drive convergent myeloerythroid defects in MDS.
PMID 42322117 — hematology, protein isoforms, chromatin, epigenome, therapeutics, rna splicing factors
Blood20262
JAK2V617F reprograms Hypoxia Inducible Factor-1 to induce a non-canonical hypoxia regulon in myeloproliferative neoplasms.
PMID 41629621 — oncogenes, genes, neoplasms, leukemia, hypoxia, regulon, hypoxia-inducible factor 1
Leukemia20260
ChIP happens: from biochemical origins to the modern omics toolbox for understanding steroid hormone receptors.
PMID 41627309 — physiology, genomics, estrogens, epigenomics, androgens, chromatin, hormones, hydrocortisone, steroids
Biochem J20260
Low-input proteomics identifies vWF as a negative regulator of Tet2 mutant hematopoietic stem cell expansion.
PMID 41447537 — cells, genes, biophysics, microscopy, electron, scanning transmission, multiple chronic conditions, stem cells, proteomics, extracellular matrix, hematopoietic stem cells
Cell Rep20250
Identification of robust RT-qPCR reference genes for studying changes in gene expression in response to hypoxia in breast cancer cell lines.
PMID 39838295 — cells, genes, genomics, breast neoplasms, neoplasms, cell line, breast, hypoxia, gene expression
BMC Genomics20250

LeadR Networks

Main global connection map